San Francisco, 8 Aug 2023: The Report Inhaled Nitric Oxide Delivery Systems Market Size, Share & Trends Analysis Report By Type (Pediatric, Adult), By Application (HRF, AHRF), By Product (Disposables, Systems), By End User, And Segment Forecasts, 2021 – 2028
The global inhaled nitric oxide delivery systems market size is estimated to reach USD 434.2 million by 2028 registering a CAGR of 6.9%, according to a new report by Grand View Research, Inc. A rise in the cases of respiratory failure among neonates, increased pollution levels leading to lung diseases in adults, need for quick treatment response, and reduced complications are the factors driving the adoption of inhaled nitric oxide therapy. The presence of several small-scale manufacturers and research initiatives undertaken by major players to prove treatment efficacy against the SARS-CoV-2 virus further enhances market growth.
Safe and effective treatment regimen, a rapid offset of action, reduced toxicity, high concentration of drug at the target organ, avoidance of systemic adverse reaction, and reduced dose of medication are some of the advantages of INO over other medications. This leads to the improved adoption of INO, potentially driving the market growth. Market leaders like Mallinckrodt Pharmaceuticals are providing fundings to conduct clinical trials of INO therapy to treat complications in COVID-19 patients. Such initiatives are said to boost the market growth during the forecasted period.
Access Research Report of Inhaled Nitric Oxide Delivery Systems Market @ https://www.grandviewresearch.com/industry-analysis/inhaled-nitric-oxide-delivery-systems-market-report
Inhaled Nitric Oxide Delivery Systems Market Report Highlights
- The pediatric type segment accounted for the largest revenue share in 2020 due to the rising usage of INO therapy on account of its efficacy and reduced complications
- The Hypoxic Respiratory Failure (HRF) application segment held the largest revenue share in 2020
- Hospitals was the largest revenue-generating segment in 2020 owing to the presence of funds and well-established infrastructure in this end-user setting
- Asia Pacific was the largest regional market in 2020 due to the growing pediatric population, rise in the cases of respiratory diseases, and presence of local manufacturers of disposables
- Some of the prominent companies are Mallinckrodt Pharmaceuticals, Getinge, Vero Biotech, LINDE, Beyond Air, SLE, Nu-MED, Bellerophon Therapeutics, Air Liquide Healthcare, and Circassia Pharmaceuticals
Inhaled Nitric Oxide Delivery Systems Market Report Scope
| Report Attribute | Details |
| The market size value in 2021 | USD 272.6 million |
| Revenue forecast in 2028 | USD 434.2 million |
| Growth rate | CAGR of 6.9% from 2021 to 2028 |
| Base year for estimation | 2020 |
| Historical data | 2016 – 2019 |
| Forecast period | 2021 – 2028 |
List of Key Players of Inhaled Nitric Oxide Delivery Systems Market
- Mallinckrodt Pharmaceuticals
- Getinge
- Vero Biotech
- LINDE
- Beyond Air
- SLE
- NU MED
- Bellerophon Therapeutics
- Air Liquide Healthcare
- Circassia Pharmaceuticals
Access Press Release of Inhaled Nitric Oxide Delivery Systems Market @ https://www.grandviewresearch.com/press-release/global-inhaled-nitric-oxide-delivery-systems-market
Market Research Insights 